Clinical Trial Update: Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 trial sponsored by the CDC evaluating the immunogenicity of an intramuscular inactivated poliovirus vaccine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Inactivated Poliovirus Vaccine (IPV) (Inactivated Poliovirus Vaccine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED